Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ERAS implementation in an urban patient population undergoing gynecologic surgery.
Brown ML, Simpson V, Clark AB, Matossian MD, Holman SL, Jernigan AM, Scheib SA, Shank J, Key A, Chapple AG, Kelly E, Nair N. Brown ML, et al. Among authors: matossian md. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):1-11. doi: 10.1016/j.bpobgyn.2022.07.009. Epub 2022 Aug 7. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 36031533 Review.
Ceritinib is a novel triple negative breast cancer therapeutic agent.
Dong S, Yousefi H, Savage IV, Okpechi SC, Wright MK, Matossian MD, Collins-Burow BM, Burow ME, Alahari SK. Dong S, et al. Among authors: matossian md. Mol Cancer. 2022 Jun 29;21(1):138. doi: 10.1186/s12943-022-01601-0. Mol Cancer. 2022. PMID: 35768871 Free PMC article.
Expression of Novel Kinase MAP3K19 in Various Cancers and Survival Correlations.
Nguyen K, Yousefi H, Cheng T, Magrath J, Hartono AB, Alzoubi M, Hebert K, Brock CK, Wright MK, Byrne CE, Rivera A, Okpechi SC, Matossian MD, Wathieu H, Elliott S, Mondrinos MJ, Lee SB, Collins-Burow BM, Alahari SK, Drewry DH, Burow ME. Nguyen K, et al. Among authors: matossian md. Front Biosci (Landmark Ed). 2022 Jun 17;27(6):196. doi: 10.31083/j.fbl2706196. Front Biosci (Landmark Ed). 2022. PMID: 35748272 Free article. Review.
In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types.
Matossian MD, Chang T, Wright MK, Burks HE, Elliott S, Sabol RA, Wathieu H, Windsor GO, Alzoubi MS, King CT, Bursavich JB, Ham AM, Savoie JJ, Nguyen K, Baddoo M, Flemington E, Sirenko O, Cromwell EF, Hebert KL, Lau F, Izadpanah R, Brown H, Sinha S, Zabaleta J, Riker AI, Moroz K, Miele L, Zea AH, Ochoa A, Bunnell BA, Collins-Burow BM, Martin EC, Burow ME. Matossian MD, et al. Clin Transl Oncol. 2022 Jan;24(1):127-144. doi: 10.1007/s12094-021-02677-8. Epub 2021 Aug 9. Clin Transl Oncol. 2022. PMID: 34370182 Free PMC article.
ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism.
Burks HE, Matossian MD, Rhodes LV, Phamduy T, Elliott S, Buechlein A, Rusch DB, Miller DFB, Nephew KP, Chrisey D, Collins-Burow BM, Burow ME. Burks HE, et al. Among authors: matossian md. Breast Cancer Res Treat. 2021 Aug;189(1):25-37. doi: 10.1007/s10549-021-06256-x. Epub 2021 Jul 6. Breast Cancer Res Treat. 2021. PMID: 34231077
NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.
Matossian MD, Elliott S, Van Hoang T, Burks HE, Wright MK, Alzoubi MS, Yan T, Chang T, Wathieu H, Windsor GO, Hartono AB, Lee S, Zuercher WJ, Drewry DH, Wells C, Kapadia N, Buechlein A, Fang F, Nephew KP, Collins-Burow BM, Burow ME. Matossian MD, et al. Breast Cancer Res Treat. 2021 Aug;189(1):49-61. doi: 10.1007/s10549-021-06295-4. Epub 2021 Jul 1. Breast Cancer Res Treat. 2021. PMID: 34196902
29 results